Evaluation of a Stepped Care Approach to Manage Depression in Diabetes

NCT01812291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2022-09-14

No results posted yet for this study

Summary

The study examines the efficacy of a stepped care approach for depressed diabetes patients (first study objective). 256 patients with diabetes and comorbid subthreshold or clinical depression will be randomly assigned to either a stepped care approach or a treatment-as-usual condition. The stepped care approach consists of three treatment steps comprising diabetes-specific cognitive-behavioral therapy (CBT) (group), depression-specific CBT (single), and psychotherapeutic and/or psychiatric treatment (single). Patients assigned to the stepped care approach will be treated stepwise until a clinically significant reduction of depressive symptoms is attained or all three treatment steps are passed.

The primary outcome of the first study objective is a clinically significant reduction of depressive symptoms in the 12-month follow-up. Secondary outcomes are reduction of diabetes-related distress and improvement of well-being, health-related quality of life, diabetes acceptance, diabetes self-care, and glycaemic control. Additionally, cost-benefit analyses will be performed.

The second study objective is to analyse associations between diabetes, depression, and the serum levels of inflammatory markers.

The third study objective is to analyse the courses of depressive conditions in diabetes with regard to recovery rates and incidence of major depression.

Conditions

Interventions

BEHAVIORAL

Step 1: Diabetes-Specific CBT (5 group sessions)

Diabetes-Specific CBT (5 group sessions) focusing on diabetes-related problems and distress ('DIAMOS - Strengthening Diabetes Motivation'). Includes: * Diabetes problem analysis/ definition * Diabetes problem solving intervention * Cognitive restructuring of diabetes problems * Activation of personal and social resources * Goal definition and agreement

BEHAVIORAL

Step 2: Depression-Specific CBT (6 single sessions)

Depression-Specific CBT (6 single sessions) focusing on depressive cognitions and affective problems (manualised). Includes: * Functional explanatory model of depression * Cognitive restructuring of negative thoughts * Practice of alternative beneficial thoughts * Specific cognitive interventions regarding self-criticism, guilt, low self-esteem, fear, and inactivity.

BEHAVIORAL

Step 3: Referral to Psychotherapist and/or Psychiatrist

Non-responders to previous treatment steps will be referred to an psychotherapist and/or psychiatrist for intensified treatment. Treatments procedures will be monitored and interventions will be scored to enable the evaluation of treatment effects.

BEHAVIORAL

Standard Diabetes Education

Standard diabetes education and professional care. Includes: * Health care and specific topics (e. g. blood pressure) * Diabetes complications * Healthy and unhealthy foods, cooking recommendations and recipes * Foot care: exercises, care and control, injuries, and diabetic neuropathy * Sports, activities and exercise * Social aspects of living with diabetes

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV
  • German Diabetes Center

    collaborator OTHER
  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER
  • University of Giessen

    collaborator OTHER
  • Helmholtz Zentrum München

    collaborator INDUSTRY
  • Coordination Center for Clinical Trials (KKS)

    collaborator UNKNOWN
  • Forschungsinstitut der Diabetes Akademie Mergentheim

    lead OTHER

Principal Investigators

  • Bernhard Kulzer, PD Dr. · Forschungsinstitut der Diabetes Akademie Mergentheim

  • Norbert Hermanns, Prof. Dr. · Forschungsinstitut der Diabetes Akademie Mergentheim

  • Thomas Haak, Prof. Dr. · Forschungsinstitut der Diabetes Akademie Mergentheim

  • Johannes Kruse, Prof. Dr. · University of Giessen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812291 on ClinicalTrials.gov